Oncology
13 drugs are in development for Endometrial Cancer.
- Companies
- 11
- Clinical trials
- 99
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Endometrial Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(10)
Phase 1/Phase 2(3)
| Drug | Company |
|---|---|
| eik1005 | Eikon Therapeutics Inc. (EIKN) |
| nc410 | NextCure, Inc. (NXTC) |
| XmAb541 | Xencor Inc (XNCR) |
About this indication
Endometrial Cancer context
Oncology·MeSH: Endometrial Neoplasms (D016889)
Narrower concept of MeSH descriptor Endometrial Neoplasms
Prevalence
58.0 / 100K
Incidence
28.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Endometrial Cancer?
BioSniper tracks 13 drugs in development for Endometrial Cancer across 11 companies.
How many clinical trials target Endometrial Cancer?
There are 99 clinical trials targeting Endometrial Cancer tracked by BioSniper.
What is the prevalence of Endometrial Cancer?
The estimated prevalence of Endometrial Cancer is approximately 58.0 per 100,000 population.